My second column at Forbes.com's The Apothecary blog discusses whether breaking up Pfizer (like almost everyone on Wall Street wants to do) is really such a good idea.
Read it here.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
1 comment:
Cool Post....
Smith Alan
kamagra
Post a Comment